PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
PTC Therapeutics (NASDAQ: PTCT) announced that CEO Matthew B. Klein, M.D., will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PTC Therapeutics (NASDAQ: PTCT) announced that CEO Matthew B. Klein, M.D., will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026 at 9:00 a.m. PST / 12:00 p.m. EST.
The presentation will be webcast live on the company’s Events and Presentations investor page at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation.
Details
News Market Reaction – PTCT
On Dec 18, the day this news came out, PTCT closed 0.47% below the previous close.
Data tracked by StockTitan Argus for the Dec 18 session.
Key Figures
- Conference edition
- 44th
- Annual J.P. Morgan Healthcare Conference
- Presentation date
- Jan. 12, 2026
- Scheduled CEO presentation time
- Presentation time PST
- 9 a.m. PST
- J.P. Morgan Healthcare Conference slot
- Presentation time EST
- 12 p.m. EST
- J.P. Morgan Healthcare Conference slot
- Webcast archive period
- 30 days
- Investor replay availability after presentation
Historical Context
-
New-hire inducement equity grants with options and RSUs under Nasdaq Rule 5635(c)(4).
-
Scheduled R&D Day to showcase small molecule splicing and inflammation platforms.
-
Reported Q3 2025 revenue, positive net income and updated full-year guidance.
-
Participation in multiple global healthcare investor conferences with webcasts.
-
Inducement equity awards for new employees with four-year vesting terms.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The presentation will be webcast live on the Events and Presentations page of the Investors section of the PTC Therapeutics website at https://ir.ptcbio.com/events-presentations, and it will be archived for 30 days following the presentation.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Facebook, and Instagram.
For More Information:
Investors:
Ellen Cavaleri
+1 (615) 618-6228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302645455.html
SOURCE PTC Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.